Rebuilding trust in proton pump inhibitor therapy  

作　　者：Alla Turshudzhyan Sonia Samuel Angela Tawfik Micheal Tadros 

机构地区：[1]Department of Medicine,University of Connecticut,Farmington,CT 06030,United States [2]Department of Medicine,Albany Medical College,Albany,NY 12208,United States [3]Guilderland High School,Guilderland Center,Albany,NY 12085,United States [4]Department of Gastroenterology and Hepatology,Albany Medical College,Albany,NY 12208,United States

出　　处：《World Journal of Gastroenterology》2022年第24期2667-2679,共13页世界胃肠病学杂志（英文版）

摘　　要：Introduction of proton pump inhibitor(PPI)therapy into clinical practice has revolutionized treatment approach to acid-related diseases.With its clinical success came a widespread use of PPI therapy.Subsequently,several studies found that PPIs were oftentimes overprescribed in primary care and emergency setting,likely attributed to seemingly low side-effect profile and physicians having low threshold to initiate therapy.However,now there is a growing concern over PPI side-effect profile among both patients and providers.We would like to bring more awareness to the currently available guidelines on PPI use,discuss clinical indications for PPIs and the evidence behind the reported sideeffects.We hope that increased awareness of proper PPI use will make the initiation or continuation of therapy a well informed and an evidence-based decision between patient and physician.We also hope that discussing evidence behind the reported side-effect profile will help clarify the growing concerns over PPI therapy.

关 键 词：Proton pump inhibitor SIDE-EFFECTS Gastro-esophageal reflux disease THERAPY 

分 类 号：R45[医药卫生—治疗学]